ParXsons Booster Drink

ParXsons™ is a dual-format nutraceutical system—Active Capsules plus Booster Drink—designed to ease tremors, improve mobility, support cognitive function and provide neuroprotective benefits without the debilitating side effects associated with conventional movement-disorder medications. Its formulations work synergistically, delivering clinically aligned doses that cannot fit into standard capsules alone. The Active Capsules combine Apium graveolens (celery seed oil 75 mg + extract 500 mg), shown in clinical trials to reduce tremors, rigidity and sleep issues through powerful neuroprotective and anti-inflammatory pathways; PQQ (20 mg) to inhibit α-synuclein fibril formation and protect neuronal integrity; Vitamin B3 (200 mg nicotinamide) for essential brain and neuronal support; Alpha Lipoic Acid (50 mg) to reduce oxidative stress and improve motor symptoms; and Ginkgo Biloba (100 mg) to slow dopaminergic neuron degeneration. Additional elements include NMN (200 mg) + Resveratrol (35 mg) as synergistic NAD⁺-supporting longevity compounds; KSM-66® Ashwagandha (200 mg) for enhanced memory, attention and processing speed; Curcumin C3 Reduct® (100 mg) to directly modulate α-synuclein aggregation; CHD-FA™ Fulvic Acid (103 mg elemental) for improved immune, cellular and gut function; CoQ10 (20 mg) for symptomatic motor improvement; and PQQ (5 mg) for additional neuroprotection. The Booster Drink amplifies effects further with Vitamin D3 (1000 IU) + K2 (40 mcg) to support ageing-related neurological resilience; Vitamin C (550 mg) for antioxidant protection and epidemiologically supported PD-risk reduction; Magnesium (144 mg) to counter neurological deficiency patterns in PD; Zinc (2.9 mg) to address inflammation-linked depletion; and a high-dose prebiotic fibre matrix (FIBERSOL-2® 5700 mg + FIBREGUM™ 3000 mg) to improve gut–brain axis function, a critical factor in contemporary neurodegeneration research. Together, these two products target both motor and non-motor PD symptoms — including tremors, gait stabilisation, sleep disturbances, autonomic dysfunction and cognitive decline — providing a powerful, safe, unscheduled neuroprotective intervention for improved quality of life.